Company Overview

We are a gene therapy company dedicated to developing and commercializing novel treatments for patients suffering from dermatological diseases. We have a proprietary gene therapy platform, which we refer to as the Skin TARgeted Delivery platform, or STAR-D platform, which we are initially using to develop treatments for rare or orphan dermatological indications.


Corporate Presentation

KB Corporate Presentation Q3 2020


Corporate Fact Sheet

KB Corporate Fact Sheet Q3 2020


Data Provided by Refinitiv. Minimum 15 minutes delayed.